TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34107742 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 34109223 — Surrogate Endpoint (SUR): Serum uric acid
Study 34109243 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34109484 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34109484 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34109484 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34109515 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 34110383 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34110383 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 34111495 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34112181 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34112707 — Predictive Biomarker (PRD): Hormone receptor
Study 34112948 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 34112948 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34113254 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 34113318 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 34113569 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34113571 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study 34114913 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34114913 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34115136 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34115385 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 34115805 — Predictive Biomarker (PRD): PROCR mRNA
Genes: PROCR; EPCR
Study 34116134 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study 34116329 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 34116533 — Safety Biomarker (SAF): MTHFR
Study 34116645 — Surrogate Endpoint (SUR): Blood pressure
Study 34116953 — Predictive Biomarker (PRD): P4HB mRNA
Genes: P4HB; ERBA2L; PDI; PDIA1; PO4DB
Study 34117510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34117601 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34117638 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 34117737 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 34117759 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34117759 — Predictive Biomarker (PRD): PSMB6 mRNA
Genes: PSMB6; LMPY; Y
Study 34118018 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 34118018 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34118197 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 34118198 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 34118361 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34118361 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 34118986 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34120214 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study 34120229 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 34120229 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 34120312 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34124781 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 34125421 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34126109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34126262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34126262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34126278 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34126939 — Monitoring Biomarker (MOI): HBV DNA
Study 34126939 — Surrogate Endpoint (SUR): Serum creatinine
Study 34126939 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 34127633 — Safety Biomarker (SAF): Reactive oxygen species
Study 34129158 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34129158 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 34129237 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 34129363 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 34129486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34129808 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 34130731 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34131041 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34131041 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 34131914 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 34134520 — Predictive Biomarker (PRD): APOC1 mRNA
Genes: APOC1
Study 34134520 — Monitoring Biomarker (MOI): Apolipoprotein C-II
Genes: APOC2; APC2
Study 34134520 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study 34134520 — Predictive Biomarker (PRD): PLTP mRNA
Genes: PLTP
Study 34134520 — Safety Biomarker (SAF): Clusterin
Genes: CLU; APOJ; CLI; KUB1; AAG4
Study 34134520 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 34134520 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 34134830 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34135471 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34135690 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 34135690 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 34135690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34135690 — Safety Biomarker (SAF): Interleukin 1
Study 34135855 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34136782 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 34136782 — Surrogate Endpoint (SUR): Serum potassium
Study 34137430 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34138449 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 34138888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34138888 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34139747 — Surrogate Endpoint (SUR): Blood pressure
Study 34140107 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34140107 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34140212 — Predictive Biomarker (PRD): PMM2 mRNA
Genes: PMM2
Study 34140248 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34140248 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34140311 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 34140403 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 34140403 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 34140403 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34140482 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34140638 — Predictive Biomarker (PRD): MDM2
Genes: HDM2; MGC5370
Study 34140638 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34141612 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34141612 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34141624 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34142073 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 34142126 — Surrogate Endpoint (SUR): Blood pressure
Study 34142256 — Monitoring Biomarker (MOI): Procalcitonin
Study 34142256 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34142256 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34143416 — Predictive Biomarker (PRD): PLN mRNA
Genes: PLN; PLB
Study 34143867 — Surrogate Endpoint (SUR): Blood pressure
Study 34143998 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34145225 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34145225 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 34145979 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 34145979 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34147313 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34149627 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 34150661 — Predictive Biomarker (PRD): Hormone receptor
Study 34150785 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 34150923 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34150923 — Predictive Biomarker (PRD): WAS mRNA
Genes: WAS; IMD2
Study 34152395 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 34153017 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34153017 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34153264 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34154614 — Predictive Biomarker (PRD): Microsatellite instability
Study 34154614 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34155864 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34155907 — Surrogate Endpoint (SUR): Blood pressure
Study 34156303 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34156525 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study 34156716 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 34156716 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 34156874 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34157782 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34157782 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34157782 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34157782 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 34157782 — Predictive Biomarker (PRD): Hormone receptor
Study 34159373 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 34160085 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34160085 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34160290 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 34160752 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34161704 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34162404 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 34162435 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34163180 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 34164554 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34164713 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34164713 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34164711 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 34164803 — Surrogate Endpoint (SUR): Blood pressure
Study 34166627 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34166998 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34166998 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34168480 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34169200 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 34169200 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34169203 — Predictive Biomarker (PRD): ROBO2 mRNA
Genes: ROBO2; KIAA1568
Study 34169203 — Predictive Biomarker (PRD): SLIT2 mRNA
Genes: SLIT2; SLIL3
Study 34171339 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 34172005 — Surrogate Endpoint (SUR): Serum creatinine
Study 34172290 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34173196 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34173341 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34173341 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34173341 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34173341 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 34173341 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34173341 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34173811 — Predictive Biomarker (PRD): ADCY9 mRNA
Genes: ADCY9; KIAA0520
Study 34173811 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 34173811 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34173822 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34173924 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34173924 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34173924 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34173924 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 34173969 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34174177 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 34174177 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34174279 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 34175021 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34175043 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34176281 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 34176286 — Surrogate Endpoint (SUR): Blood pressure
Study 34176288 — Surrogate Endpoint (SUR): Blood pressure
Study 34176681 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34178122 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34178122 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34178122 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34178122 — Predictive Biomarker (PRD): Hormone receptor
Study 34180037 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 34180037 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34183020 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34184326 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34184441 — Surrogate Endpoint (SUR): Blood pressure
Study 34185002 — Surrogate Endpoint (SUR): Blood pressure
Study 34185002 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34185084 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 34185708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34185838 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34187401 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34187401 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34187739 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34187831 — Surrogate Endpoint (SUR): Blood pressure
Study 34187841 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34187867 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34188166 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 34188166 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 34188166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34188580 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 34189463 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34190375 — Predictive Biomarker (PRD): DAXX mRNA
Genes: DAXX; BING2; DAP6
Study 34190375 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study 34190375 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 34191195 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 34191621 — Surrogate Endpoint (SUR): Blood pressure
Study 34192154 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34192989 — Safety Biomarker (SAF): Hyaluronic acid
Study 34193208 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34193208 — Monitoring Biomarker (MOI): Procalcitonin
Study 34193433 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34195252 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34195252 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34195486 — Predictive Biomarker (PRD): GRAP2 mRNA
Genes: GRAP2; GADS; GRB2L; GRID
Study 34195525 — Predictive Biomarker (PRD): PRKAR1B mRNA
Genes: PRKAR1B
Study 34195525 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 34195683 — Predictive Biomarker (PRD): PRSS3 mRNA
Genes: PRSS3; PRSS4; TRY3; TRY4
Study 34195683 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 34195683 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 34195683 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study 34195683 — Predictive Biomarker (PRD): Phospholipase A2 inhibitory protein
Genes: ANXA1; ANX1; LPC1
Study 34196037 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 34196037 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study 34196037 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34196165 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34196381 — Predictive Biomarker (PRD): TAS1R3 mRNA
Genes: TAS1R3; T1R3; TR3
Study 34196676 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34197184 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34197212 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34197212 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 34200102 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study 34200140 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 34201045 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 34208053 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 34210826 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): IL21 mRNA
Genes: IL21
Study 34210826 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34211773 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 34212476 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34212476 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 34213592 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34213636 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34213732 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34215024 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 34215317 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 34215319 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study 34215319 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 34215319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ADAM11 mRNA
Genes: ADAM11; MDC
Study 34215909 — Surrogate Endpoint (SUR): Bone mineral density
Study 34216197 — Surrogate Endpoint (SUR): Blood pressure
Study 34216247 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34216757 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34216825 — Safety Biomarker (SAF): CREM mRNA
Genes: CREM
Study 34217109 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 34217109 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 34217404 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34217908 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34217908 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34217908 — Predictive Biomarker (PRD): Hormone receptor
Study 34219663 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 34221918 — Monitoring Biomarker (MOI): HBV DNA
Study 34222435 — Monitoring Biomarker (MOI): HBV DNA
Study 34222719 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study 34222719 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34223253 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 34223895 — Surrogate Endpoint (SUR): Blood pressure
Study 34224261 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34224438 — Predictive Biomarker (PRD): TOP2A mRNA
Genes: TOP2A; TOP2
Study 34224438 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34224583 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34224668 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34224668 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK